Cargando…

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

The limited effectiveness of current therapies against Alzheimer’s disease (AD) highlights the need for intensifying research efforts devoted to developing new agents for preventing or retarding the disease process. During the last few years, targeting the endogenous cannabinoid system has emerged a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aso, Ester, Ferrer, Isidre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942876/
https://www.ncbi.nlm.nih.gov/pubmed/24634659
http://dx.doi.org/10.3389/fphar.2014.00037